AVITA Medical, Inc. - 8-K Filing

AVITA Medical reports Q3 2026 revenue of $26.1 million, up 53% YoY, and raises full-year guidance to $92M-$94M. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $RCEL

Read the full article at SEC EDGAR

More Regulatory news